World Biochips Market Analysis, Size, Share, Growth, Sales Statistics Key Players 2027

 Biochips Market Research Report: by Type (DNA Chips, Lab-On-A-Chip, and Protein Chips), by Technology (Microarrays, and Microfluidics) By End User (Biotechnology and Pharmaceutical Companies, Hospitals and Diagnostics Centers)-Forecast Till 2027

Biochips Market Scenario

Biochips market is expected to grow significantly over the forecast period. The market held a market value of USD 7,300 million in 2017 and is projected to grow at a CAGR of 16.6% over the forecast period. Biochips are intended to function in biological environment, preferably inside living organism.

Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/7063            

According to national Cancer Institute, in 2018, an estimated 1,735,350 new cases of cancer were diagnosed in the United States and 609,640 people may die from the disease.

However, high cost of the instruments and stringent regulatory guidelines may restrain the growth of the Biochips Market 

Competitive Landscape:

• Perkinelmer, Inc.,
• Fluidigm Corporation,
• Agilent Technologies, Inc.,
• Abbott Laboratories,
• Bio-Rad Laboratories Inc.,
• Cepheid Inc.,
• Illumina, Inc.,
• GE Healthcare,
• Thermo Fisher Scientific, Inc,
• Roche Diagnostics

Segmentation:

The Global Biochips Market has been segmented into type, technology, and end user.

By type, the market has been segmented into DNA chips, lab-on-a-chip, protein chips, cell arrays, and tissue arrays. DNA chips is further segmented into gene expression, SNP genotyping, cancer diagnosis & treatment, genomics, drug discovery, agricultural biotechnology, and others. Lab-on-a-chip is further segmented into clinical diagnostics, genomics, IVD (In-Vitro Diagnostic) & POC (Point of care), Proteomics, Drug Discovery, and others. Protein chips is further segmented into proteomics, expression profiling, diagnostics, high-throughput screening, drug discovery, others.

Based on technology, the market has been segmented into microarrays and microfluidics.

The biochips market, by end user, has been segmented into biotechnology and pharmaceutical companies, hospitals and diagnostics centers, academic & research institutes, and others.

Regional Market Summary

Geographically, the Americas is anticipated to dominate the global biochips market owing to the high domestic income, and presence of major market players. Moreover, increasing patient population in US. According to American Cancer Society, the overall estimate of 1,735,350 cases for 2018 equals more than 4,700 new cancer diagnoses each day.

Europe is expected to hold the second largest position in the global biochips market. The market growth in this region is attributed to the presence of strong academic & research base and availability of funding for research in the European countries. For instance, the European Research Council (ERC) provides grants for technological and scientific research conducted within the European Union (EU).

The biochips market in Asia-Pacific region consists of countries namely China, Japan, Republic of Korea, India, Australia and Rest of Asia-Pacific. The Asia-Pacific region is expected to be fastest growing region owing to increasing government focus on biomedical and biotechnology sector and growing number of target population in the region.

The Middle East & Africa has the lowest share of the global biochips market. Majority of the market of the region is anticipated to be held by the Middle East region owing to the growing government initiatives for the healthcare sector.

Browse Comprehensive Overview of Report @ https://www.marketresearchfuture.com/reports/biochips-market-7063        
About US:

 

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.